The melanocortin 4 receptor agonist setmelanotide is now FDA approved for weight management in adults and children with ...

Keratoconus is a rare, progressive ophthalmic disorder characterized by changes to the cornea that result in significant ...

Data from the phase 3b STEP UP trial demonstrate that the 7.2 mg semaglutide dose provides superior weight reduction compared ...

Scientists are making rapid progress toward a long-awaited goal that could help to reshape cancer care: mRNA cancer vaccines ...

Previously, the Company had received CRLs in November 2023 and April 2025 due to insufficient evidence in addressing the ...

A federal court blocks changes to the childhood immunization schedule by the recently appointed vaccine advisory committee; ...

Significantly lower risks for MACE, all-cause mortality, incident myocardial infarction, stroke seen for adults 50 years and older with ASCVD.

A phase 3 study of eftilagimod alfa for NSCLC is ending early due to futility, according to an update from developer Immutep.

Retatrutide is an investigational once-weekly triple hormone (glucose-dependent insulinotropic polypeptide, glucagon-like ...

Enh3ance trial results indicate DTX301 reduces ammonia levels by 18% and supports dietary liberalization in patients with OTC deficiency.

From 2023, there was a decrease in use of metabolic and bariatric surgery, with stronger decline for sleeve gastrectomy.

HealthDay News — In middle-aged and older adults, anticholinergic drug burden is associated with an increased risk for ...